0
0
0
Chronic Kidney Disease Improvement in Research and Treatment Act of 2021
12/31/2022, 4:59 AM
Summary of Bill HR 4065
Bill 117 HR 4065, also known as the Chronic Kidney Disease Improvement in Research and Treatment Act of 2021, aims to address the growing issue of chronic kidney disease (CKD) in the United States. The bill focuses on improving research and treatment options for individuals suffering from CKD.
One key aspect of the bill is the establishment of a Chronic Kidney Disease Task Force, which will be responsible for developing a comprehensive strategy to improve the prevention, diagnosis, and treatment of CKD. The task force will also work to increase awareness of CKD among healthcare providers and the general public.
Additionally, the bill includes provisions to increase funding for research into CKD, with a focus on identifying risk factors, improving early detection methods, and developing new treatment options. The goal is to ultimately reduce the prevalence of CKD and improve outcomes for individuals living with the disease. Overall, Bill 117 HR 4065 represents a bipartisan effort to address the growing public health crisis of chronic kidney disease in the United States. By focusing on research and treatment improvements, the bill aims to make a meaningful impact on the lives of individuals affected by CKD.
One key aspect of the bill is the establishment of a Chronic Kidney Disease Task Force, which will be responsible for developing a comprehensive strategy to improve the prevention, diagnosis, and treatment of CKD. The task force will also work to increase awareness of CKD among healthcare providers and the general public.
Additionally, the bill includes provisions to increase funding for research into CKD, with a focus on identifying risk factors, improving early detection methods, and developing new treatment options. The goal is to ultimately reduce the prevalence of CKD and improve outcomes for individuals living with the disease. Overall, Bill 117 HR 4065 represents a bipartisan effort to address the growing public health crisis of chronic kidney disease in the United States. By focusing on research and treatment improvements, the bill aims to make a meaningful impact on the lives of individuals affected by CKD.
Congressional Summary of HR 4065
Chronic Kidney Disease Improvement in Research and Treatment Act of 2021
This bill modifies provisions relating to Medicare coverage of treatments for chronic kidney disease.
Specifically, the bill expands the Medicare annual wellness visit to include chronic kidney disease screening and allows certain Medicare beneficiaries who have End Stage Renal Disease (ESRD) to enroll in Medicare supplemental policies. It also (1) provides for alternative payment methodologies for certain new drugs, biologics, and devices that are renal dialysis services; (2) revises quality measures; (3) establishes an incentive payment methodology; and (4) increases access to kidney disease education services.
The bill also extends the coordination period (from 30 months to 42 months) during which private health insurers may serve as the primary payers for Medicare beneficiaries with ESRD.
Read the Full Bill
Current Status of Bill HR 4065
Bill HR 4065 is currently in the status of Bill Introduced since June 22, 2021. Bill HR 4065 was introduced during Congress 117 and was introduced to the House on June 22, 2021. Bill HR 4065's most recent activity was Referred to the Subcommittee on Health. as of June 23, 2021
Bipartisan Support of Bill HR 4065
Total Number of Sponsors
1Democrat Sponsors
1Republican Sponsors
0Unaffiliated Sponsors
0Total Number of Cosponsors
18Democrat Cosponsors
14Republican Cosponsors
4Unaffiliated Cosponsors
0Policy Area and Potential Impact of Bill HR 4065
Primary Policy Focus
HealthPotential Impact Areas
- Administrative law and regulatory procedures
- Congressional oversight
- Department of Health and Human Services
- Digestive and metabolic diseases
- Drug therapy
- Government studies and investigations
- Health care costs and insurance
- Health care coverage and access
- Health care quality
- Health facilities and institutions
- Health promotion and preventive care
- Health technology, devices, supplies
- Medicaid
- Medical research
- Medical tests and diagnostic methods
- Medicare
- Minority health
- Organ and tissue donation and transplantation
- State and local government operations
Alternate Title(s) of Bill HR 4065
To improve the understanding of, and promote access to treatment for, chronic kidney disease, and for other purposes.
Chronic Kidney Disease Improvement in Research and Treatment Act of 2021
Chronic Kidney Disease Improvement in Research and Treatment Act of 2021
Comments
Sponsors and Cosponsors of HR 4065
Latest Bills
Making Reviews Certain Act
Bill HR 8249April 20, 2026
A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Bureau of Consumer Financial Protection relating to the withdrawal of the rule relating to "Consumer Financial Protection Circular 2022-07: Reasonable Investigation of Consumer Reporting Disputes".
Bill SJRES 173April 20, 2026
Expressing support for the designation of the month of April 2026 as "Parkinson's Awareness Month".
Bill HRES 1167April 20, 2026
Recognizing U.S. Immigration and Customs Enforcement for their work in protecting communities from violent criminals and illegal aliens.
Bill HRES 1168April 20, 2026
A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Bureau of Consumer Financial Protection relating to the withdrawal of the rule relating to "Consumer Financial Protection Circular 2022-02: Deceptive Representations Involving the FDIC's Name or Logo or Deposit Insurance".
Bill SJRES 175April 20, 2026
A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Bureau of Consumer Financial Protection relating to "Registry of Nonbank Covered Persons Subject to Certain Agency and Court Orders; Rescission".
Bill SJRES 177April 20, 2026
A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Bureau of Consumer Financial Protection relating to the withdrawal of the rule relating to "Disclosure of Consumer Complaint Narrative Data".
Bill SJRES 176April 20, 2026
A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Bureau of Consumer Financial Protection relating to the withdrawal of the rule relating to "Consumer Information Requests to Large Banks and Credit Unions".
Bill SJRES 167April 20, 2026
A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Bureau of Consumer Financial Protection relating to the withdrawal of the rule relating to "Consumer Financial Protection Circular 2022-04: Insufficient Data Protection or Security for Sensitive Consumer Information".
Bill SJRES 164April 20, 2026
A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Bureau of Consumer Financial Protection relating to the withdrawal of the rule relating to "Bulletin 2015-02 re: Section 8 housing choice voucher homeownership program".
Bill SJRES 165April 20, 2026